HZNP Medicines LLC v. Actavis Laboratories UT, Inc.

Case Number: CLB0455

Date: 10.10.2019

Citation: (2017-2149 Fed. Cir. 2019)

When interpreting formulation claims that include “consisting essentially of” language the reasonable certainty standard for indefiniteness must be applied to the “basic and novel” properties of the invention.

Download PDF Return to Case Law Briefs Main Page